Thursday, February 08, 2018 10:08:37 AM
All of this while entirely fluffing off any risk whatsoever with, it's biotech. Well it's not. It's Pluristem. Want to take a look at the risks, read the Edison report. Don't just look at the parts you want to hear.
Look at the part that talks about the most potential beneficial patients that enrolled in the hip fracture study. The questioning of the size of that market. The need for future dilution. The huge risk of jumping to stage 3 trials. The risk of having zero statistically significant numbers in any human trials with results. Others as well.
And let's not forget the giant risk of putting your money in the hands of people who are incapable of running a Biotech company. You know, with all the questionable clowns and how nobody on this board can come up with any reason whatsoever that justifies their belief that they CAN run a company. Some feeble attempts by one, but easily shot down.
Ask yourself this. How or why would any retail investor try to own 200,000 shares at over a quarter of a million dollars. Someone who is absolutely loaded maybe. But if that were the case, does anyone really think they'd be wasting their time posting here? Not likely.
I'm not sure what you mean by "I'll reconsider" there Happy. Not sure what you read of Zzatt's post that has given you renewed confidence in Pluristem. But it just proves my point.
Not sure what being under $1.40 should be called now. Steal of the century. But trying to lure investors in during pumps and all the way down should be called crime of the century.
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM